The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
Mesa Biotech
Mesa Biotech lands $13M to develop rapid COVID/flu test
Mesa Biotech announced today that it was awarded $13 million by BARDA to develop its COVID-19 and flu molecular diagnostic. San Diego-based Mesa Biotech received the contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and […]
NIH puts $249m into new COVID-19 tests
The National Institutes of Health (NIH) announced today that it is investing $248.7 million in new technologies to address challenges with COVID-19 testing. The “Rapid Acceleration of Diagnostics” (RADx) initiative awarded contracts to seven biomedical diagnostic companies to support lab-based and point-of-care tests that could significantly increase the number, type and availability of tests by […]
Mesa ships 10,000 COVID-19 rapid tests
Mesa Biotech announced today that it is shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point-of-care tests this week for detecting COVID-19. The San Diego-based company’s palm-sized testing platform is designed to enable “near-patient” testing outside a central laboratory with diagnostic results in 30 minutes. Accula uses reverse transcription polymerase chain reaction (RT-PCR) technology to […]
Everlywell, Nurx to offer at-home COVID-19 tests
Home testing company Everlywell said today that it will launch a home test kit with telehealth diagnosis for COVID-19 on Monday. The Austin, Texas-based company said it will release 30,000 tests immediately and is working with multiple labs to have testing and diagnosis capacity for a quarter of a million people weekly. Consumers who have […]
